Mandatory Prescription Drug Monitoring to Combat Controlled Substance Misuse.
This Act mandates that practitioners and dispensers use state Prescription Drug Monitoring Programs (PDMPs) when prescribing and dispensing controlled substances (like opioids). The goal is to curb substance misuse by detecting suspicious patterns early. Citizens will experience increased oversight in the process of obtaining certain medications, which is intended to enhance safety and reduce addiction risks. States failing to comply with these requirements risk losing federal grant funding for drug monitoring programs.
Key points
Practitioners must consult the state PDMP before initiating treatment with Schedule II, III, or IV controlled substances, and every 3 months thereafter.
Dispensers (pharmacies) must report every controlled substance prescription to the PDMP within 24 hours of dispensing the drug to the patient.
PDMP systems must proactively notify practitioners when patterns indicative of controlled substance misuse, including opioid misuse, are detected.
State agencies administering PDMPs must analyze data and report practitioners repeatedly falling outside expected norms to law enforcement and licensing boards.
Expired
Citizen Poll